• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素治疗轴性和颈部肌张力障碍。

Botulinum toxin treatment of axial and cervical dystonia.

作者信息

Benecke Reiner, Dressler Dirk

机构信息

Department of Neurology, Rostock University, Germany.

出版信息

Disabil Rehabil. 2007 Dec 15;29(23):1769-77. doi: 10.1080/01421590701568262.

DOI:10.1080/01421590701568262
PMID:18033602
Abstract

Axial truncal dystonia is characterized by an abnormal trunk posture often superimposed by myoclonic motor activities. Cervical dystonia is a motor syndrome characterized by abnormal head and neck posture due to tonic involuntary contractions in a certain set of muscles often superimposed by myoclonic or tremulous movements. Intramuscular injection of botulinum toxin is the first line treatment in cervical dystonia, in axial truncal dystonias botulinum toxin therapy is used only in mild forms. In this review the theoretical background, practical aspects and efficacy results especially in cervical dystonia are presented. Treatment of axial trunk dystonia is only briefly discussed at the beginning of this review.

摘要

轴性躯干肌张力障碍的特征是躯干姿势异常,常伴有肌阵挛性运动活动。颈部肌张力障碍是一种运动综合征,其特征是由于特定一组肌肉的强直性不自主收缩导致头颈部姿势异常,常伴有肌阵挛或震颤运动。肉毒杆菌毒素肌肉注射是颈部肌张力障碍的一线治疗方法,在轴性躯干肌张力障碍中,肉毒杆菌毒素疗法仅用于轻度病例。本综述介绍了理论背景、实际应用方面以及尤其是颈部肌张力障碍的疗效结果。本文仅在开头简要讨论了轴性躯干肌张力障碍的治疗。

相似文献

1
Botulinum toxin treatment of axial and cervical dystonia.肉毒杆菌毒素治疗轴性和颈部肌张力障碍。
Disabil Rehabil. 2007 Dec 15;29(23):1769-77. doi: 10.1080/01421590701568262.
2
Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.回复:初治的颈部肌张力障碍患者中B型肉毒毒素与A型肉毒毒素的对比:随机、双盲、非劣效性试验。
Mov Disord. 2009 May 15;24(7):1098-9; author reply 1100. doi: 10.1002/mds.22339.
3
Botulinum toxin therapy for cervical dystonia.肉毒杆菌毒素治疗颈部肌张力障碍
Phys Med Rehabil Clin N Am. 2003 Nov;14(4):749-66, vi. doi: 10.1016/s1047-9651(03)00045-7.
4
[Treatment of focal dystonia with botulinum toxin A].[肉毒杆菌毒素A治疗局限性肌张力障碍]
Wien Klin Wochenschr. 2001;113 Suppl 4:6-10.
5
Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.肉毒杆菌毒素治疗眼睑痉挛和口下颌肌张力障碍:不同肉毒杆菌毒素制剂的比较
Eur J Neurol. 2006 Feb;13 Suppl 1:21-9. doi: 10.1111/j.1468-1331.2006.01441.x.
6
[Cervical dystonia--diagnosis and treatment].[颈部肌张力障碍——诊断与治疗]
Tidsskr Nor Laegeforen. 2008 Oct 9;128(19):2202-5.
7
Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.肉毒毒素治疗痉挛性斜颈的肌肉选择:系统评价。
Parkinsonism Relat Disord. 2012 Jul;18(6):731-6. doi: 10.1016/j.parkreldis.2012.04.005. Epub 2012 May 8.
8
Craniocervical dystonia: clinical and pathophysiological features.颅颈肌张力障碍:临床和病理生理学特征。
Eur J Neurol. 2010 Jul;17 Suppl 1:15-21. doi: 10.1111/j.1468-1331.2010.03045.x.
9
Utility of an EMG mapping study in treating cervical dystonia.肌电图定位研究在治疗颈部肌张力障碍中的应用
Muscle Nerve. 2000 Nov;23(11):1752-6. doi: 10.1002/1097-4598(200011)23:11<1752::aid-mus12>3.0.co;2-u.
10
[Clinical symptoms, diagnosis and treatment of focal dystonias].[局灶性肌张力障碍的临床症状、诊断与治疗]
Orv Hetil. 2001 Oct 21;142(42):2293-7.

引用本文的文献

1
Globus Pallidus Internus Deep Brain Stimulation for Dystonic Opisthotonus in Adult-Onset Dystonia: A Personalized Approach.苍白球内侧部脑深部电刺激治疗成人起病性肌张力障碍所致角弓反张:一种个性化方法
Front Hum Neurosci. 2021 Jun 10;15:683545. doi: 10.3389/fnhum.2021.683545. eCollection 2021.
2
Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study.肉毒杆菌毒素治疗下特发性肌张力障碍患者的照顾者负担及健康相关生活质量:一项横断面研究
J Neural Transm (Vienna). 2020 Jan;127(1):61-70. doi: 10.1007/s00702-019-02109-6. Epub 2019 Dec 4.
3
Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions.
肉毒杆菌神经毒素-A 经立体定向脑内注射到半帕金森病大鼠中,可改善左、右手正向和反向前肢的起始时间。
Int J Mol Sci. 2019 Feb 25;20(4):992. doi: 10.3390/ijms20040992.
4
Botulinum toxin therapy for cervical dystonia: the science of dosing.肉毒杆菌毒素治疗颈部肌张力障碍:剂量科学
Tremor Other Hyperkinet Mov (N Y). 2014 Nov 12;4:273. doi: 10.7916/D84X56BF. eCollection 2014.
5
Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.使用BoTest基质分析法从复杂基质中分离和定量肉毒杆菌神经毒素。
J Vis Exp. 2014 Mar 3(85):51170. doi: 10.3791/51170.
6
The focal dystonias: current views and challenges for future research.局限性肌张力障碍:当前的观点和未来研究的挑战。
Mov Disord. 2013 Jun 15;28(7):926-43. doi: 10.1002/mds.25567.
7
Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.以皮摩尔到飞摩尔灵敏度在复杂基质中检测 A、B 和 F 型肉毒神经毒素的蛋白水解活性。
Appl Environ Microbiol. 2012 Nov;78(21):7687-97. doi: 10.1128/AEM.01664-12. Epub 2012 Aug 24.
8
Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations.两种不同 BoNT/A 衍生制剂的效力和抗原性的比较评估。
J Neural Transm (Vienna). 2013 Feb;120(2):291-8. doi: 10.1007/s00702-012-0854-3. Epub 2012 Jul 29.
9
Current and future medical treatment in primary dystonia.原发性肌张力障碍的当前和未来的治疗方法。
Ther Adv Neurol Disord. 2012 Jul;5(4):221-40. doi: 10.1177/1756285612447261.
10
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease.A型肉毒毒素与康复计划治疗帕金森病中的 Pisa 综合征
J Neurol. 2010 Jan;257(1):139-41. doi: 10.1007/s00415-009-5310-4.